Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1979 4
1981 2
1983 7
1984 8
1985 8
1986 8
1987 9
1988 7
1989 10
1990 15
1991 12
1992 9
1993 9
1994 12
1995 11
1996 13
1997 11
1998 11
1999 23
2000 15
2001 25
2002 24
2003 28
2004 22
2005 25
2006 26
2007 38
2008 34
2009 40
2010 39
2011 49
2012 32
2013 39
2014 56
2015 47
2016 44
2017 43
2018 27
2019 38
2020 31
2021 27
2022 24
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

876 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Colorectal Adenocarcinoma Metastatic in the Liver"
Page 1
Regional Therapy for Colorectal Cancer Liver Metastases: Which Modality and When?
Raphael MJ, Karanicolas PJ. Raphael MJ, et al. J Clin Oncol. 2022 Aug 20;40(24):2806-2817. doi: 10.1200/JCO.21.02505. Epub 2022 Jun 1. J Clin Oncol. 2022. PMID: 35649228 Review.
For patients with unresectable colorectal liver metastases (uCRLM), regional therapies leverage the unique, dual blood supply to the liver; the hepatic artery is the main blood supply for liver tumors, whereas the portal vein supplies most normal hepat …
For patients with unresectable colorectal liver metastases (uCRLM), regional therapies leverage the unique, dual blood supply …
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer.
Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, Neuberg D, Huang K, Guevara F, Nelson T, Chipashvili O, Hagan T, Walker M, Ramachandran A, Diosdado B, Serna G, Mulet N, Landolfi S, Ramon Y Cajal S, Fasani R, Aguirre AJ, Ng K, Élez E, Ogino S, Tabernero J, Fuchs CS, Hahn WC, Nuciforo P, Meyerson M. Bullman S, et al. Science. 2017 Dec 15;358(6369):1443-1448. doi: 10.1126/science.aal5240. Epub 2017 Nov 23. Science. 2017. PMID: 29170280 Free PMC article.
Fusobacterium nucleatum is among the most prevalent bacterial species in colorectal cancer tissues. Here we show that colonization of human colorectal cancers with Fusobacterium and its associated microbiome-including Bacteroides, Selenomonas, and Prevotella species …
Fusobacterium nucleatum is among the most prevalent bacterial species in colorectal cancer tissues. Here we show that colonization of …
Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer.
Zhang KL, Zhu WW, Wang SH, Gao C, Pan JJ, Du ZG, Lu L, Jia HL, Dong QZ, Chen JH, Lu M, Qin LX. Zhang KL, et al. Theranostics. 2021 Apr 27;11(13):6560-6572. doi: 10.7150/thno.55609. eCollection 2021. Theranostics. 2021. PMID: 33995676 Free PMC article.
Here we sought to investigate the functional mechanism of cholesterol metabolic aberration in colorectal carcinoma (CRC) liver metastasis. Methods: The expression of cholesterol metabolism-related genes in primary colorectal tumors (PT) and paired liver …
Here we sought to investigate the functional mechanism of cholesterol metabolic aberration in colorectal carcinoma (CRC) liver …
Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA(+) Metastatic Colorectal Cancers.
Zhang C, Wang Z, Yang Z, Wang M, Li S, Li Y, Zhang R, Xiong Z, Wei Z, Shen J, Luo Y, Zhang Q, Liu L, Qin H, Liu W, Wu F, Chen W, Pan F, Zhang X, Bie P, Liang H, Pecher G, Qian C. Zhang C, et al. Mol Ther. 2017 May 3;25(5):1248-1258. doi: 10.1016/j.ymthe.2017.03.010. Epub 2017 Mar 31. Mol Ther. 2017. PMID: 28366766 Free PMC article. Clinical Trial.
In this study, we investigated CAR-T therapy targeting carcino-embryonic antigen (CEA)-positive colorectal cancer (CRC) patients with metastases to evaluate its safety and efficacy. ...
In this study, we investigated CAR-T therapy targeting carcino-embryonic antigen (CEA)-positive colorectal cancer (CRC) patients with …
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
Cercek A, Boerner T, Tan BR, Chou JF, Gönen M, Boucher TM, Hauser HF, Do RKG, Lowery MA, Harding JJ, Varghese AM, Reidy-Lagunes D, Saltz L, Schultz N, Kingham TP, D'Angelica MI, DeMatteo RP, Drebin JA, Allen PJ, Balachandran VP, Lim KH, Sanchez-Vega F, Vachharajani N, Majella Doyle MB, Fields RC, Hawkins WG, Strasberg SM, Chapman WC, Diaz LA Jr, Kemeny NE, Jarnagin WR. Cercek A, et al. JAMA Oncol. 2020 Jan 1;6(1):60-67. doi: 10.1001/jamaoncol.2019.3718. JAMA Oncol. 2020. PMID: 31670750 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: A single-institution, phase 2 clinical trial including 38 patients was conducted with HAI floxuridine plus systemic gemcitabine and oxaliplatin in patients with unresectable IHC at Memorial Sloan Kettering Cancer Center between May …
DESIGN, SETTING, AND PARTICIPANTS: A single-institution, phase 2 clinical trial including 38 patients was conducted with HAI f …
Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.
Miura JT, Gamblin TC. Miura JT, et al. Surg Oncol Clin N Am. 2015 Jan;24(1):149-66. doi: 10.1016/j.soc.2014.09.004. Epub 2014 Oct 7. Surg Oncol Clin N Am. 2015. PMID: 25444473 Review.
Management of liver malignancies, both primary and metastatic, requires a host of treatment modalities when attempting to prolong survival. ...In this article, the current role along with future perspectives of transarterial chemoembolization for hepatocellular carc …
Management of liver malignancies, both primary and metastatic, requires a host of treatment modalities when attempting to prol …
Liver transplantation for malignancies.
Eghtesad B, Aucejo F. Eghtesad B, et al. J Gastrointest Cancer. 2014 Sep;45(3):353-62. doi: 10.1007/s12029-014-9590-2. J Gastrointest Cancer. 2014. PMID: 24604263 Review.
Liver transplantation (LT) has become an acceptable and effective treatment for selected patients with hepatocellular carcinoma with excellent outcomes. More recently, LT has been tried in different primary and secondary malignancies of the liver. The outcome …
Liver transplantation (LT) has become an acceptable and effective treatment for selected patients with hepatocellular carcinoma with …
Multidisciplinary treatment of colorectal liver metastases.
Schiergens TS, von Einem J, Thomas MN, Albertsmeier M, Giessen-Jung C, Dörsch M, Heiliger C, Drefs M, Andrassy J, Modest DP, Stintzing S, Guba M, Angele M, Werner J, Rentsch M. Schiergens TS, et al. Minerva Med. 2017 Dec;108(6):527-546. doi: 10.23736/S0026-4806.17.05371-X. Epub 2017 Sep 8. Minerva Med. 2017. PMID: 28889727 Review.
INTRODUCTION: The therapy of patients with colorectal liver metastases (CRLM) has undergone significant changes. ...Depending on the hepatic tumor burden and its dynamics as well as the type and stage of the primary tumor, simultaneous resection or either the sequen …
INTRODUCTION: The therapy of patients with colorectal liver metastases (CRLM) has undergone significant changes. ...Depending …
Carbon-ion Radiotherapy for Oligometastatic Colorectal Cancer in the Liver or Lung.
Shiba S, Shibuya K, Okamoto M, Okano N, Kubo N, Kaminuma T, Sato H, Okazaki S, Miyasaka Y, Kawamura H, Ohno T. Shiba S, et al. Anticancer Res. 2021 Apr;41(4):1997-2005. doi: 10.21873/anticanres.14967. Anticancer Res. 2021. PMID: 33813406
BACKGROUND/AIM: We aimed to evaluate the clinical outcomes of oligometastatic colorectal cancer in the liver and lung treated with carbon-ion radiotherapy (C-ion RT). ...None of the patients developed grade 2 or higher acute or late toxicities. CONCLUSION: C- …
BACKGROUND/AIM: We aimed to evaluate the clinical outcomes of oligometastatic colorectal cancer in the liver and lung t …
Management of resectable colorectal lung metastases.
Moorcraft SY, Ladas G, Bowcock A, Chau I. Moorcraft SY, et al. Clin Exp Metastasis. 2016 Mar;33(3):285-96. doi: 10.1007/s10585-015-9774-6. Epub 2015 Dec 10. Clin Exp Metastasis. 2016. PMID: 26659389 Review.
Lung metastases occur in 10-20 % of patients with colorectal cancer. The biology of colorectal lung metastases is poorly understood, however lung metastases are more common in patients with rectal cancer and in patients with RAS mutations. ...This article summarizes …
Lung metastases occur in 10-20 % of patients with colorectal cancer. The biology of colorectal lung metastases is poorly under …
876 results